Chart: Sen. Hatch Has Seven Questions About FDA's Structure And Resources

Executive Summary

Sen. Orrin Hatch, R-Utah, concluded his speech at the FDA/Food and Drug Law Institute's Annual Meeting on April 22 by asking the audience a series of questions. Some were clearly rhetorical; others emphasized his affection for the dietary supplement industry, but the list highlights what one of the health arena's more powerful actors believes are the thorniest issues facing FDA at the moment. "All of you need to think long and hard about the answers to these questions," Hatch told the audience. "That being said, this is not a test." Below is a transcript of the remarks, with the topic of the questions bolded.